{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:45:43Z","timestamp":1794012343564,"version":"4.8.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T00:00:00Z","timestamp":1625443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Early and persistent activation of complement is considered to play a key role in the pathogenesis of COVID-19. Complement activation products orchestrate a proinflammatory environment that might be critical for the induction and maintenance of a severe inflammatory response to SARS-CoV-2 by recruiting cells of the cellular immune system to the sites of infection and shifting their state of activation towards an inflammatory phenotype. It precedes pathophysiological milestone events like the cytokine storm, progressive endothelial injury triggering microangiopathy, and further complement activation, and causes an acute respiratory distress syndrome (ARDS). To date, the application of antiviral drugs and corticosteroids have shown efficacy in the early stages of SARS-CoV-2 infection, but failed to ameliorate disease severity in patients who progressed to severe COVID-19 pathology. This report demonstrates that lectin pathway (LP) recognition molecules of the complement system, such as MBL, FCN-2 and CL-11, bind to SARS-CoV-2 S- and N-proteins, with subsequent activation of LP-mediated C3b and C4b deposition. In addition, our results confirm and underline that the N-protein of SARS-CoV-2 binds directly to the LP- effector enzyme MASP-2 and activates complement. Inhibition of the LP using an inhibitory monoclonal antibody against MASP-2 effectively blocks LP-mediated complement activation. FACS analyses using transfected HEK-293 cells expressing SARS-CoV-2 S protein confirm a robust LP-dependent C3b deposition on the cell surface which is inhibited by the MASP-2 inhibitory antibody. In light of our present results, and the encouraging performance of our clinical candidate MASP-2 inhibitor Narsoplimab in recently published clinical trials, we suggest that the targeting of MASP-2 provides an unsurpassed window of therapeutic efficacy for the treatment of severe COVID-19.<\/jats:p>","DOI":"10.3389\/fimmu.2021.714511","type":"journal-article","created":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T04:25:56Z","timestamp":1625459156000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":159,"title":["Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins"],"prefix":"10.3389","volume":"12","author":[{"given":"Youssif M.","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadam","family":"Yaseen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Dudler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasha","family":"Gragerov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Demopulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Heeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelm J.","family":"Schwaeble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2020.04.020","article-title":"Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An Overview of Viral Structure and Host Response","volume":"14","author":"Astuti","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.8255","article-title":"Use of Prone Positioning in Nonintubated Patients With COVID-19 and Hypoxemic Acute Respiratory Failure","volume":"323","author":"Elharrar","year":"2020","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.05.006","article-title":"Acute Kidney Injury in Patients Hospitalized With COVID-19","volume":"98","author":"Hirsch","year":"2020","journal-title":"Kidney Int"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1718709115","article-title":"Structure of the C1r-C1s Interaction of the C1 Complex of Complement Activation","volume":"115","author":"Almitairi","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1078\/0171-2985-00146","article-title":"The Mannan-Binding Lectin-Associated Serine Proteases (MASPs) and MAp19: Four Components of the Lectin Pathway Activation Complex Encoded by Two Genes","volume":"205","author":"Schwaeble","year":"2002","journal-title":"Immunobiology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nri800","article-title":"Evolution of the Lectin-Complement Pathway and its Role in Innate Immunity","volume":"2","author":"Fujita","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1179\/096805105225006704","article-title":"Production and Purification of Recombinants of Mouse MASP-2 and sMAP","volume":"11","author":"Iwaki","year":"2005","journal-title":"J Endotoxin Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.065805","article-title":"A Novel Mannose-Binding Lectin\/Ficolin-Associated Protein is Highly Expressed in Heart and Skeletal Muscle Tissues and Inhibits Complement Activation","volume":"285","author":"Skjoedt","year":"2010","journal-title":"J Biol Chem"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201601306R","article-title":"Lectin Pathway Effector Enzyme Mannan-Binding Lectin-Associated Serine Protease-2 can Activate Native Complement C3 in Absence of C4 and\/or C2","volume":"31","author":"Yaseen","year":"2017","journal-title":"FASEB J"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(08)04004-2","article-title":"The Amplification Loop of the Complement Pathways","volume":"104","author":"Lachmann","year":"2009","journal-title":"Adv Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa646","article-title":"Complement Activation in the Disease Course of Coronavirus Disease 2019 and Its Effects on Clinical Outcomes","volume":"223","author":"de Nooijer","year":"2021","journal-title":"J Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2010540117","article-title":"Systemic Complement Activation is Associated With Respiratory Failure in COVID-19 Hospitalized Patients","volume":"117","author":"Holter","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01753-18","article-title":"Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis","volume":"9","author":"Gralinski","year":"2018","journal-title":"mBio"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement Associated Microvascular Injury and Thrombosis in the Pathogenesis of Severe COVID-19 Infection: A Report of Five Cases","volume":"220","author":"Magro","year":"2020","journal-title":"Transl Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.05.002","article-title":"Enterococcus Faecalis Escapes Complement-Mediated Killing via Recruitment of Complement Factor H","volume":"220","author":"Ali","year":"2019","journal-title":"J Infect Dis"},{"key":"B16","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2020.05.002","article-title":"Immunology of COVID-19: Current State of the Science","volume":"52","author":"Vabret","year":"2020","journal-title":"Immunity"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.140711","article-title":"The Complement System in COVID-19: Friend and Foe","volume":"5","author":"Java","year":"2020","journal-title":"JCI Insight"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0320-7","article-title":"Complement as a Target in COVID-19","volume":"20","author":"Risitano","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa627","article-title":"Focal Small Bowel Thrombotic Microvascular Injury in COVID-19 Mediated by the Lectin Complement Pathway Masquerading as Lupus Enteritis","volume":"60","author":"Plotz","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.29.20041962","article-title":"Highly Pathogenic Coronavirus N Protein Aggravates Lung Injury by MASP-2-Mediated Complement Over-Activation","author":"Ting","year":"2020","journal-title":"medRxiv"},{"key":"B21","doi-asserted-by":"publisher","first-page":"152001","DOI":"10.1016\/j.imbio.2020.152001","article-title":"Endothelial Injury and Thrombotic Microangiopathy in COVID-19: Treatment With the Lectin-Pathway Inhibitor Narsoplimab","volume":"225","author":"Rambaldi","year":"2020","journal-title":"Immunobiology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"108490","DOI":"10.1016\/j.clim.2020.108490","article-title":"Treating COVID-19 With Colchicine in Community Healthcare Setting","volume":"217","author":"Della-Torre","year":"2020","journal-title":"Clin Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202004_20875","article-title":"Eculizumab Treatment in Patients With COVID-19: Preliminary Results From Real Life ASL Napoli 2 Nord Experience","volume":"24","author":"Diurno","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/pathogens10020217","article-title":"Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19","volume":"10","author":"Ho","year":"2021","journal-title":"Pathogens"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2020.1771181","article-title":"Old and Re-Purposed Drugs for the Treatment of COVID-19","volume":"18","author":"Jean","year":"2020","journal-title":"Expert Rev Anti Infect Ther"},{"key":"B26","doi-asserted-by":"publisher","first-page":"108450","DOI":"10.1016\/j.clim.2020.108450","article-title":"The First Case of COVID-19 Treated With the Complement C3 Inhibitor AMY-101","volume":"215","author":"Mastaglio","year":"2020","journal-title":"Clin Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"108598","DOI":"10.1016\/j.clim.2020.108598","article-title":"Complement C3 vs C5 Inhibition in Severe COVID-19: Early Clinical Findings Reveal Differential Biological Efficacy","volume":"220","author":"Mastellos","year":"2020","journal-title":"Clin Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.714511\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T04:25:59Z","timestamp":1625459159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.714511\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,5]]},"references-count":27,"alternative-id":["10.3389\/fimmu.2021.714511"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.714511","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,5]]},"article-number":"714511"}}